Julia Post
Overview
Explore the profile of Julia Post including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, et al.
Heliyon
. 2023 Aug;
9(8):e18443.
PMID: 37609390
Disease-modifying therapies to treat Alzheimer's disease (AD) are of fundamental interest for aging humans, societies, and health care systems. Predictable disease progression in transgenic AD models favors preclinical studies employing...
2.
Wintz K, Post J, Langen K, Willbold D, Willuweit A, Kutzsche J
Biomedicines
. 2023 May;
11(4).
PMID: 37189613
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting upper and lower motor neurons, thus, progressing to complete muscle loss until the patient dies from respiratory arrest. The disease is...
3.
Post J, Schaffrath A, Gering I, Hartwig S, Lehr S, Jon Shah N, et al.
Int J Mol Sci
. 2021 Jul;
22(13).
PMID: 34209129
Neuroinflammation is a pathological hallmark of several neurodegenerative disorders and plays a key role in the pathogenesis of amyotrophic lateral sclerosis (ALS). It has been implicated as driver of disease...
4.
Post J, Kogel V, Schaffrath A, Lohmann P, Jon Shah N, Langen K, et al.
Molecules
. 2021 Apr;
26(6).
PMID: 33805709
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterised by selective neuronal death in the brain stem and spinal cord. The cause is unknown, but an increasing amount of...
5.
6.
7.
Lerner R, Post J, Loch S, Lutz B, Bindila L
Biochim Biophys Acta Mol Cell Biol Lipids
. 2016 Nov;
1862(2):255-267.
PMID: 27871881
Epilepsy is a highly common chronic neurological disorder, manifested in many different types, affecting ~1% of the worldwide human population. The molecular mechanisms of epileptogenesis have not yet been clarified,...
8.
Leithold L, Jiang N, Post J, Niemietz N, Schartmann E, Ziehm T, et al.
Eur J Pharm Sci
. 2016 Apr;
89:31-8.
PMID: 27086111
Peptides are more and more considered for the development of drug candidates. However, they frequently exhibit severe disadvantages such as instability and unfavourable pharmacokinetic properties. Many peptides are rapidly cleared...
9.
Leithold L, Jiang N, Post J, Ziehm T, Schartmann E, Kutzsche J, et al.
Pharm Res
. 2015 Sep;
33(2):328-36.
PMID: 26381279
Purpose: It has been shown that amyloid β (Aβ) oligomers play an important role in the pathology of Alzheimer's disease (AD). D3, a peptide consisting solely of D-enantiomeric amino acid...
10.
Jiang N, Leithold L, Post J, Ziehm T, Mauler J, Gremer L, et al.
PLoS One
. 2015 Jun;
10(6):e0128553.
PMID: 26046986
Targeting toxic amyloid beta (Aβ) oligomers is currently a very attractive drug development strategy for treatment of Alzheimer´s disease. Using mirror-image phage display against Aβ1-42, we have previously identified the...